Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-24-028592
Filing Date
2024-07-22
Accepted
2024-07-19 21:12:46
Documents
8
Effectiveness Date
2024-07-22

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 111234
2 LEGAL OPINION ex5-1.htm EX-5.1 16702
3 AUDITOR CONSENT ex23-1.htm EX-23.1 4036
4 FORM OF STOCK OPTION AGREEMENT ex99-2.htm EX-99.2 64889
5 FORM OF RESTRICTED STOCK GRANT AGREEMENT ex99-3.htm EX-99.3 40136
6 FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT ex99-4.htm EX-99.4 45561
7 CALCULATION OF FILING FEE TABLE ex107.htm EX-FILING FEES 40658
8 ex5-1_001.jpg GRAPHIC 44403
  Complete submission text file 0001493152-24-028592.txt   385556
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280929 | Film No.: 241129102
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)